✦ LIBER ✦

Radioimmunoguided surgery using the monoclonal antibody B72.3 in colorectal tumors

✍ Scribed by Brenda J. Sickle-Santanello; Patric J. O'Dwyer; Cathy Mojzisik; Steven E. Tuttle; George H. Hinkle; Michel Rousseau; Jeffrey Schlom; David Colcher; Marlin O. Thurston; Carol Nieroda; Armando Sardi; William B. Farrar; John P. Minton; Edward W. Martin

Book ID: 112780196
Publisher: Springer
Year: 1987
Tongue: English
Weight: 529 KB
Volume: 30
Category: Article
ISSN: 0012-3706
DOI: 10.1007/bf02554623

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of radioimmunoguided surgery using

Role of radioimmunoguided surgery using Iodine-125-labeled B72.3 monoclonal antibody in gastric cancer surgery

✍ Enzo Lucisano; Sergio Bertoglio 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 26 KB

Uniform and accurate staging of gastric cancer is essential to predict prognosis and assess the effectiveness of treatment strategies. An appropriate amount of surgical resection of the primary tumor and lymph node dissection appears to be fundamental for such staging. In seven out of 10 patients wh

Enhancement of colorectal tumor targetin

Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery

✍ Jin C. Kim; Seon A. Roh; Kum H. Koo; Jang H. Ryu; Hyun K. Hong; Seung J. Oh; Jin 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 543 KB

## Abstract Biparatopic CEA, carcinoembryonic antigen (MAb) was newly designed and tested as to whether it enhanced the accuracy of tumor detection by reducing non‐specific binding in experimental radioimmunoguided surgery. Biparatopic MAb was prepared by using cross‐linking of reduced Fab′ fragmen

Feasibility study of radioimmunoguided s

Feasibility study of radioimmunoguided surgery of colorectal carcinomas using indium-111 CEA-specific monoclonal antibody

✍ C. Curtet; J. P. Vuillez; G. Daniela; G. Aillet; A. Chetanneau; J. Visset; M. Kr 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 568 KB

Radioimmunoguided surgery in gastric can

Radioimmunoguided surgery in gastric cancer using 131-I labeled monoclonal antibody 3H11

✍ Dr. Guangwei Xu; Meiying Zhang; Baoguo Liu; Zhenfu Li; Baohe Lin; Xiaobao Xu; Ma 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 478 KB

## Abstract A clinical trial of radioimmunoguided surgery (RIGS) using 131‐I labeled monoclonal antibody (MAb) 3H11 was performed on 25 cases with gastric cancer in this study. The results showed that the route of the administration of radiolabeled MAb is the key point of successful RIGS for gastri

A radioimmunoassay for the detection of

A radioimmunoassay for the detection of a human tumor-associated glycoprotein (tag-72) using monoclonal antibody B72.3

✍ Andrew J. Paterson; Jeffrey Schlom; Henry F. Sears; Jeffrey Bennett; David Colch 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 French ⚖ 846 KB

Monoclonal antibody (MAb) 872.3 was generated against a carcinoma metastasis and has been shown to bind with a high degree of selectivity to a tumorassociated glycoprotein (TAG-72) found in human CO- Ion and breast carcinomas, while showing minimal reactivity to any normal adult tissues. Competition

Novel clinical approaches in monoclonal

Novel clinical approaches in monoclonal antibody-based management in colorectal cancer patients: Radioimmunoguided surgery and antigen augmentation

✍ Mario Roselli; Oreste Buonomo; Antonina Piazza; Fiorella Guadagni; Aldo Vecchion 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Surgery, the most effective treatment for colon and rectal cancer, is based on empirical knowledge of the patterns of tumor spread, gross findings at laparotomy, and histologic confirmation of tumor-free margins. In spite of the many technical improvements in surgery, there has not been a significan